Factors associated with the informal use of HIV pre‐exposure prophylaxis in Germany: a cross‐sectional study

INTRODUCTION: Until September 2019, pre‐exposure prophylaxis (PrEP) with tenofovir disoproxil/emtricitabine for HIV prevention was not covered by health insurance plans in Germany, and was only available through private prescriptions with self‐pay or through informal non‐prescription sources. The ob...

Descripción completa

Detalles Bibliográficos
Autores principales: Koppe, Uwe, Marcus, Ulrich, Albrecht, Stefan, Jansen, Klaus, Jessen, Heiko, Gunsenheimer‐Bartmeyer, Barbara, Bremer, Viviane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776824/
https://www.ncbi.nlm.nih.gov/pubmed/31583823
http://dx.doi.org/10.1002/jia2.25395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776824/
https://www.ncbi.nlm.nih.gov/pubmed/31583823
http://dx.doi.org/10.1002/jia2.25395

Ejemplares similares